Aura Biosciences, Inc. (AURA)
AURA Stock Price Chart
Explore Aura Biosciences, Inc. interactive price chart. Choose custom timeframes to analyze AURA price movements and trends.
AURA Company Profile
Discover essential business fundamentals and corporate details for Aura Biosciences, Inc. (AURA) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
29 Oct 2021
Employees
106.00
Website
https://www.aurabiosciences.comCEO
Elisabet de los Pinos
Description
Headquartered in Cambridge, Massachusetts, Aura Biosciences, Inc. is a biotechnology firm established in 2009 that specializes in pioneering cancer treatments. The company leverages its proprietary virus-like drug conjugate (VDC) technology platform to address tumors with significant unmet medical needs, specifically in ocular (eye) and urologic oncology. Its flagship therapeutic candidate, AU-011, is a VDC currently in development for the treatment of primary choroidal melanoma. Furthermore, Aura Biosciences is investigating AU-011's potential for other ocular oncology applications, such as choroidal metastases.
AURA Financial Timeline
Browse a chronological timeline of Aura Biosciences, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 12 Aug 2026
EPS estimate is -$0.41.
Earnings released on 11 May 2026
EPS came in at -$0.50 falling short of the estimated -$0.40 by -25.00%.
Earnings released on 30 Mar 2026
EPS came in at -$0.37 surpassing the estimated -$0.43 by +13.95%.
Earnings released on 13 Nov 2025
EPS came in at -$0.40 surpassing the estimated -$0.46 by +13.04%.
Earnings released on 13 Aug 2025
EPS came in at -$0.47 surpassing the estimated -$0.49 by +4.08%.
Earnings released on 15 May 2025
EPS came in at -$0.55 falling short of the estimated -$0.47 by -17.02%.
Earnings released on 24 Mar 2025
EPS came in at -$0.52 falling short of the estimated -$0.43 by -20.93%.
Earnings released on 12 Nov 2024
EPS came in at -$0.42 surpassing the estimated -$0.44 by +4.55%.
Earnings released on 8 Aug 2024
EPS came in at -$0.41 surpassing the estimated -$0.45 by +8.89%.
Earnings released on 9 May 2024
EPS came in at -$0.40 surpassing the estimated -$0.51 by +21.57%.
Earnings released on 27 Mar 2024
EPS came in at -$0.50 falling short of the estimated -$0.39 by -28.21%, while revenue for the quarter reached $2.06m .
Earnings released on 9 Nov 2023
EPS came in at -$0.48 surpassing the estimated -$0.54 by +11.11%.
Earnings released on 9 Aug 2023
EPS came in at -$0.48 surpassing the estimated -$0.49 by +2.04%.
Earnings released on 11 May 2023
EPS came in at -$0.46 surpassing the estimated -$0.52 by +11.54%.
Earnings released on 15 Mar 2023
EPS came in at -$0.52 surpassing the estimated -$0.58 by +10.34%.
Earnings released on 10 Nov 2022
EPS came in at -$0.53 falling short of the estimated -$0.52 by -1.92%.
Earnings released on 11 Aug 2022
EPS came in at -$0.46 surpassing the estimated -$0.48 by +4.17%.
Earnings released on 12 May 2022
EPS came in at -$0.44 matching the estimated -$0.44.
Earnings released on 23 Mar 2022
EPS came in at -$2.51 falling short of the estimated -$0.39 by -543.59%.
Earnings released on 24 Nov 2021
EPS came in at -$0.32 .
Earnings released on 1 Nov 2021
EPS came in at -$0.45 .
AURA Stock Performance
Access detailed AURA performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
